Literature DB >> 20140137

Heparin revisions: a call for heightened vigilance and monitoring.

Walter Alexander.   

Abstract

Entities:  

Year:  2009        PMID： 20140137      PMCID： PMC2810166     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


× No keyword cloud information.
  2 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Contaminated heparin associated with adverse clinical events and activation of the contact system.

Authors:  Takashi Kei Kishimoto; Karthik Viswanathan; Tanmoy Ganguly; Subbiah Elankumaran; Sean Smith; Kevin Pelzer; Jonathan C Lansing; Nammalwar Sriranganathan; Ganlin Zhao; Zoya Galcheva-Gargova; Ali Al-Hakim; Gregory Scott Bailey; Blair Fraser; Sucharita Roy; Thomas Rogers-Cotrone; Lucinda Buhse; Mark Whary; James Fox; Moheb Nasr; Gerald J Dal Pan; Zachary Shriver; Robert S Langer; Ganesh Venkataraman; K Frank Austen; Janet Woodcock; Ram Sasisekharan
Journal:  N Engl J Med       Date:  2008-04-23       Impact factor: 91.245
  2 in total
  2 in total

1.  How one academic medical center has managed potency changes with unfractionated heparin.

Authors:  Jeffery Lalama; Patrick M Lewis; Joel Gore; Maichi T Tran; Jennifer Donovan
Journal:  J Thromb Thrombolysis       Date:  2013-07       Impact factor: 2.300

2.  Heparin at physiological concentration can enhance PEG-free in vitro infection with human hepatitis B virus.

Authors:  Gansukh Choijilsuren; Ren-Shiang Jhou; Shu-Fan Chou; Ching-Jen Chang; Hwai-I Yang; Yang-Yuan Chen; Wan-Long Chuang; Ming-Lung Yu; Chiaho Shih
Journal:  Sci Rep       Date:  2017-10-31       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.